Evidence map›Paper›PMID 12556480›Full record

ArticleMolecular and cellular biology2003

Potentiation of protein kinase C zeta activity by 15-deoxy-delta(12,14)-prostaglandin J(2) induces an imbalance between mitogen-activated protein kinases and NF-kappa B that promotes apoptosis in macrophages.

Antonio Castrillo, Paqui G Través, Paloma Martín-Sanz, Scott Parkinson, Peter J Parker, Lisardo Boscá

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 40 citations in OpenAlex.

  1. Induction of Heme Oxygenase-1 by 15d-Prostaglandin JAntioxidants (Basel, Switzerland) · 2022
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. 15-Deoxy-ΔMediators of inflammation · 2017
    Article
  7. Article
  8. Article
  9. Resolving the problem of persistence in the switch from acute to chronic inflammation.Proceedings of the National Academy of Sciences of the United States of America · 2007
    Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Antonio CastrilloInstituto de Bioquímica, Centro Mixto CSIC-UCM, Facultad de Farmacia, and Centro Nacional de Investigaciones Cardiovasculares, 28040 Madrid, Spain.
Paqui G Través
Paloma Martín-Sanz
Scott Parkinson
Peter J Parker
Lisardo Boscá
Consejo Superior de Investigaciones Científicas · ESCancer Research UK · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Activation of the macrophage cell line RAW 264.7 with lipopolysaccharide (LPS) transiently activates protein kinase C zeta (PKC zeta) and Jun N-terminal kinase (JNK) through a phosphoinositide-3-kinase (PI3-kinase)-dependent pathway. Incubation of LPS-treated cells with the cyclopentenone 15-deoxy-Delta(12,14)-prostaglandin J(2) (15dPGJ(2)) promoted a sustained activation of PKC zeta and JNK and inhibited I kappa B kinase (IKK) and NF-kappa B activity. Accordingly, 15dPGJ(2) induced an imbalance between JNK and IKK activities by increasing the former signaling pathway and inhibiting the latter signaling pathway. Under these conditions, apoptosis was significantly enhanced; this response was very dependent on PKC zeta and JNK activation. The effect of 15dPGJ(2) on PKC zeta activity observed in LPS-activated macrophages was not dependent on a direct action of this prostaglandin on the enzyme but was due to the activation of a step upstream of PI3-kinase. Moreover, LPS promoted the redistribution of activated PKC zeta from the cytosol to the nucleus, a process that was enhanced by treatment of the cells with 15dPGJ(2) that favored a persistent and broader distribution of PKC zeta in the nucleus. These results indicate that 15dPGJ(2) and other cyclopentenone prostaglandins, through the sustained activation of PKC zeta, might contribute significantly to the process of resolution of inflammation by promoting apoptosis of activated macrophages.

Indexed as

3-Phosphoinositide-Dependent Protein KinasesAnimalsApoptosisCell NucleusCells, CulturedEnzyme ActivationI-kappa B KinaseImmunologic FactorsInflammationIsoenzymesJNK Mitogen-Activated Protein KinasesLipopolysaccharidesMacrophage ActivationMacrophagesMiceMitogen-Activated Protein Kinases15-deoxy-delta(12,14)-prostaglandin J23-Phosphoinositide-Dependent Protein KinasesChuk protein, mouseI-kappa B KinaseIkbkb protein, mouseIkbke protein, mouseImmunologic FactorsIsoenzymesJNK Mitogen-Activated Protein KinasesLipopolysaccharidesMitogen-Activated Protein KinasesNF-kappa BPhosphatidylinositol 3-KinasesProstaglandin D2Protein Kinase Cprotein kinase C etaProtein Serine-Threonine Kinases

Identifiers

PMID12556480
PMCPMC141130
OpenAlexW2096461459

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.